![Robert Kramer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 909 $ in data 31/05/2026
Robert Alan Kramer was the founder of SalvaRx Group Plc, founded in 2007, where the title held was Chief Scientific Officer.
Current jobs include Director at Phusis Therapeutics, Inc. since 2014, Director at iOx Therapeutics Ltd. since 2022, and Chief Scientific Officer at AlphaTON Capital Corp.
since 2019.
Former jobs include Head-Oncology Discovery Research at Janssen Pharmaceuticals, Inc., Head-Oncology Discovery Research at Bristol-Myers Squibb Pharmaceuticals Ltd., and Assistant Professor at Harvard Medical School.
Education includes a doctorate from the University of Vermont.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ALPHA COMPUTE CORP 0,04% | 21/07/2025 | 5.038 ( 0,04% ) | 1 909 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALPHA COMPUTE CORP | Direttore Tecnico/Scientifico/R&S | 08/01/2019 |
Phusis Therapeutics, Inc.
 Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Direttore/Membro del Consiglio | 05/05/2014 |
iOx Therapeutics Ltd.
 iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Direttore/Membro del Consiglio | 15/02/2022 |
| Società | Posizione | Fine |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
| SALVARX GROUP PLC | Fondatore | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
AlphaTON Capital Corp.
 AlphaTON Capital Corp. Packaged SoftwareTechnology Services Operates as an AI compute infrastructure company that provides hardware-enforced GPU as a service solutions | Technology Services |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phusis Therapeutics, Inc.
Phusis Therapeutics, Inc. BiotechnologyHealth Technology Develops novel targeted small molecule therapeutics | Health Technology |
iOx Therapeutics Ltd.
iOx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops liposomal iNKT agonists | Health Technology |
SalvaRx Group Plc
 SalvaRx Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company that focuses on immune-oncology & invests in novel cancer immune-therapies | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
